Pramipexole


SIFROL 3.15 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 2.62 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 2.1 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 1.57 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 1.05 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.52 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.26 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 1.1 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.7 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.35 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.18 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


SIFROL 0.088 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs


Pramipexole Teva 0.7 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs


Pramipexole Teva 0.18 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs


Pramipexole Teva 0.088 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs


Oprymea 1.1 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs


Oprymea 0.7 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs


Oprymea 0.35 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs


Oprymea 0.18 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs


Oprymea 0.088 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs


Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK